daily
The Signal — April 16, 2026
Two of the biggest AI labs spent this week jockeying for position in the most consequential arena they can find: national security. Meanwhile, a federal class-action in San Francisco is asking whether the AI industry's favorite selling point (making doctors' lives easier) crosses a line that patients